相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels
Lillian Harboe Goncalves et al.
CLINICA CHIMICA ACTA (2014)
Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function
R. P. Raghavan et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation
V. Capra et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Relationship Between Platelet and Urinary 8-Iso-PGF2α Levels in Subjects With Different Degrees of NOX2 Regulation
Roberto Carnevale et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2
Pasquale Pignatelli et al.
CIRCULATION (2012)
Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
Roberto Cangemi et al.
DIABETES (2012)
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin
Kjell S. Sakariassen et al.
THROMBOSIS RESEARCH (2012)
Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction
Pasquale Pignatelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs
Presta Ivan et al.
ATHEROSCLEROSIS (2011)
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis
Sonia Butalia et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2011)
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus
Francesca Santilli et al.
INTERNAL AND EMERGENCY MEDICINE (2011)
NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation
Stefania Basili et al.
LIVER INTERNATIONAL (2011)
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
Giorgia De Berardis et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension
Francesco Perticone et al.
DIABETES (2008)
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity
P. Newsholme et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Aspirin for the primary prevention of cardiovascular events in women and men - A sex-specific meta-analysis of randomized controlled trials
JS Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
JA Beckman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Prognostic significance of endothelial dysfunction in hypertensive patients
F Perticone et al.
CIRCULATION (2001)
Obesity and body fat distribution induce endothelial dysfunction by oxidative stress - Protective effect of vitamin C
F Perticone et al.
DIABETES (2001)
分享论文
